Iterum Therapeutics PLC - Trending symbols
Notifications
Type | Notification | Date |
---|---|---|
RSI Oversold | Oversold RSI (Relative Strength Index) | 2025-04-17 |
Trends
2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Income Tax Expense | 142 | -94 | 48 | -17 | 31 | 105 | 136 | -591 | -455 | |
Depreciation and Amortization | 440 | -433 | 7 | 1 | 8 | 0 | 8 | -31 | -23 | |
Interest Expense | 405 | 82 | 487 | 84 | 571 | 19 | 590 | -4,760 | -4,170 | |
Net Working Capital | 36,824 | -14,693 | 22,131 | -10,053 | 12,078 | -10,818 | 1,260 | -4,340 | -3,080 | |
Total Stockholder Equity | 27,999 | -9,042 | 18,957 | -11,828 | 7,129 | -3,697 | 3,432 | -9,835 | -6,403 | |
Other Current Liabilities | 7,046 | -4,004 | 3,042 | 25,823 | 28,865 | -22,807 | 6,058 | -8,636 | -2,578 | |
Reconciled Depreciation | 1,773 | -1,315 | 458 | -3 | 455 | -7 | 448 | -812 | -364 | |
Net Interest Income | -772 | -267 | -1,039 | 273 | -766 | 130 | -636 | 716 | 80 | |
Tax Provision | 352 | -181 | 171 | 256 | 427 | -84 | 343 | -913 | -570 | |
Total Other Income Expense Net | 8,967 | -6,149 | 2,818 | 1,482 | 4,300 | -2,642 | 1,658 | -24,303 | -22,645 | |
Net Debt | -10,884 | 2,683 | -8,201 | -9,061 | -17,262 | 8,011 | -9,251 | 23,615 | 14,364 | |
Research Development | 2,351 | 100 | 2,451 | 263 | 2,714 | -869 | 1,845 | -19,567 | -17,722 | |
Total Operating Expenses | 4,644 | 1,203 | 5,847 | 1,140 | 6,987 | -2,113 | 4,874 | -19,469 | -14,595 |
Comments
How you think about this?